237 related articles for article (PubMed ID: 26892631)
21. Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
Roth CG; Gillespie-Twardy A; Marks S; Agha M; Raptis A; Hou JZ; Farah R; Lin Y; Qian Y; Pantanowitz L; Boyiadzis M
Oncol Res; 2016; 23(3):137-46. PubMed ID: 26931436
[TBL] [Abstract][Full Text] [Related]
22. MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
[TBL] [Abstract][Full Text] [Related]
23. Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.
Kim A; Stevenson P; Cassaday RD; Soma L; Fromm JR; Gopal AK; Smith SD; Till B; Lynch RC; Ujjani C; Shadman M; Warren EH; Menon M; Russell K; Tseng YD
Pract Radiat Oncol; 2020; 10(1):44-52. PubMed ID: 31585205
[TBL] [Abstract][Full Text] [Related]
24. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
[TBL] [Abstract][Full Text] [Related]
25. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
Johnson SM; Umakanthan JM; Yuan J; Fedoriw Y; Bociek RG; Kaiser-Rogers K; Sanmann JN; Montgomery ND
Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
[TBL] [Abstract][Full Text] [Related]
26. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.
Rosenthal A; Younes A
Blood Rev; 2017 Mar; 31(2):37-42. PubMed ID: 27717585
[TBL] [Abstract][Full Text] [Related]
27. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.
Kanagal-Shamanna R; Medeiros LJ; Lu G; Wang SA; Manning JT; Lin P; Penn GM; Young KH; You MJ; Vega F; Bassett R; Miranda RN
Histopathology; 2012 Nov; 61(5):945-54. PubMed ID: 22804688
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
[TBL] [Abstract][Full Text] [Related]
29. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
30. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
31. Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
Chiu A; Frizzera G; Mathew S; Hyjek EM; Chadburn A; Tam W; Knowles DM; Orazi A
Mod Pathol; 2009 Nov; 22(11):1507-17. PubMed ID: 19633642
[TBL] [Abstract][Full Text] [Related]
32. Double-hit and double-expressor primary central nervous system lymphoma: Experience from North India of an infrequent but aggressive variant.
Parkhi M; Chatterjee D; Radotra BD; Bal A; Yadav BS; Tripathi M
Surg Neurol Int; 2023; 14():172. PubMed ID: 37292392
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
[TBL] [Abstract][Full Text] [Related]
34. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
[TBL] [Abstract][Full Text] [Related]
35. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract][Full Text] [Related]
36. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
[TBL] [Abstract][Full Text] [Related]
37. Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with
Miyaoka M; Kikuti YY; Carreras J; Ito A; Ikoma H; Tomita S; Kawada H; Roncador G; Bea S; Campo E; Nakamura N
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497332
[TBL] [Abstract][Full Text] [Related]
38. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Gebauer N; Bernard V; Gebauer W; Thorns C; Feller AC; Merz H
Leuk Lymphoma; 2015 Jan; 56(1):179-85. PubMed ID: 24679006
[TBL] [Abstract][Full Text] [Related]
39. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.
Turakhia SK; Hill BT; Dufresne SD; Nakashima MO; Cotta CV
Am J Clin Pathol; 2014 Sep; 142(3):339-46. PubMed ID: 25125624
[TBL] [Abstract][Full Text] [Related]
40. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
Lin P; Jones D; Dorfman DM; Medeiros LJ
Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]